| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
1 Department of Biological Sciences, University of Warwick, Coventry CV4 7AL, UK
2 Microbiology and Tumorbiology Center, Karolinska Institute, S-105 21 Stockholm, Sweden
Monoclonal antibody (MAb) ICR41.1i (rat IgG2a) is specific for a conformation-dependent epitope of human immunodeficiency virus type 1 (HIV-1) V3, and MAb F58 (mouse IgG1) recognizes the peptide IXXGPGR, at the tip of the V3 loop. Both MAbs neutralized HIV-1 strain IIIB in C8166 and HeLa-T4(CD4) cells. Neutralization by either MAb did not inhibit attachment of virus to target cells as determined by FACS analysis, ELISA or immuno-fluorescence, and such attachment was absolutely dependent on the availability of CD4 molecules. F58 inhibited virus-induced cell-cell fusion, and reduced internalization of virions in direct proportion to neutralization. In contrast, ICR41.1i had no effect on HIV-1-mediated cell fusion or on internalization of virus. It was concluded that MAb F58 neutralized infectivity by inhibiting fusion of the virus with the cell and internalization of the viral core, and that ICR41. 1i neutralized by inhibiting a post-fusion-internalization event. The possible mechanism by which a neutralizing antibody binds to the V3 loop and affects the function(s) of structures inside the virion is discussed. Lastly, post-attachment neutralization (PAN) was investigated. F58 mediated PAN at 21 °C and 35 °C. However, ICR41. 1i gave PAN at 21 °C but not at 35 °C, suggesting that a temperature-dependent event affecting the V3 loop had abrogated neutralization. Overall, it appears that antibodies to different epitopes within the V3 loop neutralize by affecting very different functions of the virus.
Received 12 December 1995;
accepted 21 August 1996.
This article has been cited by other articles:
|
|
 |
|
  C. J. Heap, S. A. Reading, and N. J. Dimmock An antibody specific for the C-terminal tail of the gp41 transmembrane protein of human immunodeficiency virus type 1 mediates post-attachment neutralization, probably through inhibition of virus-cell fusion J. Gen. Virol., May 1, 2005; 86(5): 1499 - 1507. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Cheung, L. McLain, M. J. Hollier, S. A. Reading, and N. J. Dimmock Part of the C-terminal tail of the envelope gp41 transmembrane glycoprotein of human immunodeficiency virus type 1 is exposed on the surface of infected cells and is involved in virus-mediated cell fusion J. Gen. Virol., January 1, 2005; 86(1): 131 - 138. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. J. Klasse and Q. J. Sattentau Occupancy and mechanism in antibody-mediated neutralization of animal viruses J. Gen. Virol., September 1, 2002; 83(9): 2091 - 2108. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. J. Edwards and N. J. Dimmock Hemagglutinin 1-Specific Immunoglobulin G and Fab Molecules Mediate Postattachment Neutralization of Influenza A Virus by Inhibition of an Early Fusion Event J. Virol., November 1, 2001; 75(21): 10208 - 10218. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Spenlehauer, A. Kirn, A.-M. Aubertin, and C. Moog Antibody-Mediated Neutralization of Primary Human Immunodeficiency Virus Type 1 Isolates: Investigation of the Mechanism of Inhibition J. Virol., March 1, 2001; 75(5): 2235 - 2245. [Abstract] [Full Text]
|
|
|
|
|
|
F. Taguchi and Y. K. Shimazaki Functional analysis of an epitope in the S2 subunit of the murine coronavirus spike protein: involvement in fusion activity J. Gen. Virol., December 1, 2000; 81(12): 2867 - 2871. [Abstract] [Full Text]
|
|
|
|
|
|
S. M. Cleveland, T. D. Jones, and N. J. Dimmock Properties of a neutralizing antibody that recognizes a conformational form of epitope ERDRD in the gp41 C-terminal tail of human immunodeficiency virus type 1 J. Gen. Virol., May 1, 2000; 81(5): 1251 - 1260. [Abstract] [Full Text]
|
|
|
|
|
|
N. Jackson, M Levi, B Wahren, and N. Dimmock Properties and mechanism of action of a 17 amino acid, V3 loop-specific microantibody that binds to and neutralizes human immunodeficiency virus type 1 virions J. Gen. Virol., January 1, 1999; 80(1): 225 - 236. [Abstract]
|
|
|
|
|
|
P. N. Nyambi, M. K. Gorny, L. Bastiani, G. van der Groen, C. Williams, and S. Zolla-Pazner Mapping of Epitopes Exposed on Intact Human Immunodeficiency Virus Type 1 (HIV-1) Virions: a New Strategy for Studying the Immunologic Relatedness of HIV-1 J. Virol., November 1, 1998; 72(11): 9384 - 9391. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Cecilia, V. N. KewalRamani, J. O'Leary, B. Volsky, P. Nyambi, S. Burda, S. Xu, D. R. Littman, and S. Zolla-Pazner Neutralization Profiles of Primary Human Immunodeficiency Virus Type 1 Isolates in the Context of Coreceptor Usage J. Virol., September 1, 1998; 72(9): 6988 - 6996. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. W. H. I. Parren, I. Mondor, D. Naniche, H. J. Ditzel, P. J. Klasse, D. R. Burton, and Q. J. Sattentau Neutralization of Human Immunodeficiency Virus Type 1 by Antibody to gp120 Is Determined Primarily by Occupancy of Sites on the Virion Irrespective of Epitope Specificity J. Virol., May 1, 1998; 72(5): 3512 - 3519. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Mondor, S. Ugolini, and Q. J. Sattentau Human Immunodeficiency Virus Type 1 Attachment to HeLa CD4 Cells Is CD4 Independent and gp120 Dependent and Requires Cell Surface Heparans J. Virol., May 1, 1998; 72(5): 3623 - 3634. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Ugolini, I. Mondor, P. W.H.I. Parren, D. R. Burton, S. A. Tilley, P. J. Klasse, and Q. J. Sattentau Inhibition of Virus Attachment to CD4+ Target Cells Is a Major Mechanism of T Cell Line-adapted HIV-1 Neutralization J. Exp. Med., October 20, 1997; 186(8): 1287 - 1298. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| INT J SYST EVOL MICROBIOL | MICROBIOLOGY | J GEN VIROL |
| J MED MICROBIOL | ALL SGM JOURNALS | |
